Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Allogeneic Hematopoietic Stem Cell Transplantation: early-phase trial registry
3 of 4 indexed Allogeneic Hematopoietic Stem Cell Transplantation trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Allogeneic Hematopoietic Stem Cell Transplantation: 4 US clinical trials tracked, 3 recruiting.
Allogeneic Hematopoietic Stem Cell Transplantation is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Mehdi Hamadani, running 1 of these trials.
Enrollment posture brief
Registry condition allogeneic-hematopoietic-stem-cell-transplantation
OPEN 3 | RECR 75% | LATE 0 | EARLY 3 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)
Allogeneic Hematopoietic Stem Cell Transplantation lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Allogeneic Hematopoietic Stem Cell Transplantation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Allogeneic Hematopoietic Stem Cell Transplantation is recruiting above its size-band peers.
3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Nutrition OUtReach In Systems of Healthcare
University of Kansas Medical Center
NCT06802406
Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation
University of California, Irvine
NCT06028828
Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantation
Mari Dallas
NCT03378102
MLN9708 for the Prophylaxis of Chronic Graft-versus-host Disease in Patient Undergoing Allogeneic Transplantation
Mehdi Hamadani
NCT02250300
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Allogeneic Hematopoietic Stem Cell Transplantation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Allogeneic Hematopoietic Stem Cell Transplantation trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Allogeneic Hematopoietic Stem Cell Transplantation page
4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Allogeneic Hematopoietic Stem Cell Transplantation trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Mehdi Hamadani sponsors the most Allogeneic Hematopoietic Stem Cell Transplantation trials on record, review their full trial history before evaluating a specific study. See Mehdi Hamadani's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Allogeneic Hematopoietic Stem Cell Transplantation condition card totals 4 registered trials; most-linked intervention MLN9708 (3.0 mg); top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.